Trial NCT00622401

View at ClinicalTrials.gov 
Aliases: NCT00731406
Org. Study IDs: 03-221
Secondary IDs: NCI 6040 P30CA006516 U01CA062490

Last trial update was posted on 2017-11-14

MeSH Interventions

Interleukin-12 Vaccines

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

In the conduct of the study, it became apparent that the setting of advanced breast cancer with malignant effusions/ascites for vaccine generation was a difficult setting for evaluation of an immune based therapy.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID